Andreas K. Bergmann

Hennigsdorf, BB 16761, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Influence of adrenomedullin on the enzymatic activity of dipeptidyl peptidase 3 in vitro.

Influence of adrenomedullin on the enzymatic activity of dipeptidyl peptidase 3 in vitro.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: July 13, 2026

Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3.

Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3.

Journal: mAbs

Published: May 21, 2026

Safety, tolerability, and pharmacokinetics/-dynamics of the dipeptidyl peptidase 3-inhibiting antibody Procizumab in a first-in-human trial.

Safety, tolerability, and pharmacokinetics/-dynamics of the dipeptidyl peptidase 3-inhibiting antibody Procizumab in a first-in-human trial.

Journal: mAbs

Published: May 21, 2026

Takotsubo syndrome diagnosis: the biomarker-based BioTAK score.

Takotsubo syndrome diagnosis: the biomarker-based BioTAK score.

Journal: European heart journal

Published: May 13, 2026

Adrenomedullin system dysregulation predicts cardiogenic shock and mortality in acute coronary syndromes.

Adrenomedullin system dysregulation predicts cardiogenic shock and mortality in acute coronary syndromes.

Journal: European heart journal

Published: February 20, 2026

Correction: Kinetics of adrenomedullin pathway activation in a porcine sepsis model and a human cohort of sepsis and septic shock.

Correction: Kinetics of adrenomedullin pathway activation in a porcine sepsis model and a human cohort of sepsis and septic shock.

Journal: Scientific reports

Published: November 04, 2025

Kinetics of adrenomedullin pathway activation in a porcine sepsis model and a human cohort of sepsis and septic shock.

Kinetics of adrenomedullin pathway activation in a porcine sepsis model and a human cohort of sepsis and septic shock.

Journal: Scientific reports

Published: March 07, 2025

Enibarcimab for the treatment of septic shock in patients selected by a combination of the biomarkers bio-ADM and DPP3: A prespecified subgroup analysis of the AdrenOSS-2 trial.

Enibarcimab for the treatment of septic shock in patients selected by a combination of the biomarkers bio-ADM and DPP3: A prespecified subgroup analysis of the AdrenOSS-2 trial.

Journal: Journal of critical care

Published: January 24, 2025

Enhancing Stability and Bioavailability of Peptidylglycine Alpha-Amidating Monooxygenase in Circulation for Clinical Use.

Enhancing Stability and Bioavailability of Peptidylglycine Alpha-Amidating Monooxygenase in Circulation for Clinical Use.

Journal: Biomolecules

Published: December 17, 2024

Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD.

Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD.

Journal: Atherosclerosis

Published: December 04, 2024

Biological characterization of AB-343, a novel and potent SARS-CoV-2 Mpro inhibitor with pan-coronavirus activity.

Biological characterization of AB-343, a novel and potent SARS-CoV-2 Mpro inhibitor with pan-coronavirus activity.

Journal: Antiviral research

Published: August 30, 2024

Sandwich immunoassay for adrenomedullin precursor and its practical application.

Sandwich immunoassay for adrenomedullin precursor and its practical application.

Journal: Scientific reports

Published: July 02, 2024

Showing 1-12 of 114

Last Updated: 09/26/2026